Evidence map›Paper›PMID 35847848›Full record

ArticleFrontiers in oncology2022

Red Light Phototherapy Using Light-Emitting Diodes Inhibits Melanoma Proliferation and Alters Tumor Microenvironments.

Evan Austin, Alisen Huang, Jennifer Y Wang, Marc Cohen, Edward Heilman, Emanual Maverakis, Josef Michl, Jared Jagdeo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Ultrasound-assisted laser therapy for selective removal of melanoma cells.Experimental biology and medicine (Maywood, N.J.) · 2024
    Article
  6. Newly Synthesized CoFeInternational journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Evan AustinDepartment of Dermatology, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, United States.
Alisen HuangDepartment of Dermatology, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, United States.
Jennifer Y WangDepartment of Dermatology, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, United States.
Marc CohenDepartment of Dermatology, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, United States.
Edward HeilmanDepartment of Dermatology, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, United States.
Emanual MaverakisDepartment of Dermatology, University of California (UC) Davis Medical Center, Sacramento, CA, United States.
Josef MichlDepartment of Pathology, SUNY Downstate Medical Center, Brooklyn, NY, United States.
Jared JagdeoDepartment of Dermatology, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, United States.
SUNY Downstate Health Sciences University · USUniversity of California Davis Medical Center · USState University of New York · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
NCI NIH HHS P30 CA093373
6 · The paper itself

Abstract

Background: Total annual cancer rates have decreased due to improved treatment and prevention. However, the incidence of melanoma is rising, and not all patients respond to immune and targeted approaches. Therefore, we sought to determine the efficacy of red light (RL) phototherapy in preclinical models of melanoma. Methods: Melanoma cells (A375, B16F10, MNT-1) were irradiated with RL. Melanoma proliferation, apoptosis, oxidative stress, and p53 phosphorylation were measured Results: Conclusion: RL represents a potentially safe and effective melanoma therapeutic. RL prevented tumor growth and increased the expression of immune markers, such as CD103, that are associated with favorable melanoma outcomes. Further research is needed to determine the optimal clinical treatment regimen for melanoma using RL.

Indexed as

low level light therapymelanomaphotobiomodulation therapyphototherapyreactive oxygen speciestumor micro environment

Identifiers

PMID35847848
PMCPMC9278815
OpenAlexW4283464322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.